Article
Novartis, Amgen and Mallinckrodt used aggressive price hikes to meet sales goals, congressional pro
Rating:
0.0
Views:
117
Likes:
1
Library:
1
Novartis, Amgen and Mallinckrodt relied on routine price hikes to meet their financial targets—and to make sure they could keep increasing prices, they worked to inhibit competition and keep their monopoly pricing power, a congressional committee said Thursday as hearings continued on Capitol Hill.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value